Uveal Melanoma-associated Mutations in PLCβ4 Are Constitutively Activating and Promote Melanocyte Proliferation and Tumorigenesis
Overview
Physiology
Science
Affiliations
Activating mutations in Gα proteins are frequent in uveal melanoma, the most common eye cancer arising from the uveal tract. A small proportion of uveal melanomas have a D630Y mutation in phospholipase C β4 (PLCβ4), an effector of Gα. Here, we found that the D630Y mutation in PLCβ4 results in a high level of constitutive PLCβ4 activity. Mutations at the corresponding position in other PLC isoforms also resulted in constitutive activity, revealing an unrecognized mechanism underlying PLC activation. In cultured human uveal melanoma cell lines, inhibition of PLC suppressed proliferation in Gα-dependent cells. Furthermore, we found that PLCβ4(D630Y) mediated proliferation in cutaneous melanocytes and the growth of melanomas in mice. These results are consistent with PLCβ4(D630Y) driving oncogenic signaling downstream of Gα.
Genetic Features of Uveal Melanoma.
Sorrentino F, Culiersi C, Florido A, De Nadai K, Adamo G, Nasini F Genes (Basel). 2024; 15(11).
PMID: 39596556 PMC: 11593461. DOI: 10.3390/genes15111356.
Recent Advances in Molecular and Genetic Research on Uveal Melanoma.
Fuentes-Rodriguez A, Mitchell A, Guerin S, Landreville S Cells. 2024; 13(12.
PMID: 38920653 PMC: 11201764. DOI: 10.3390/cells13121023.
Biophysical characterization of the CXC chemokine receptor 2 ligands.
Martin P, Kurth E, Budean D, Momplaisir N, Qu E, Simien J PLoS One. 2024; 19(4):e0298418.
PMID: 38625857 PMC: 11020491. DOI: 10.1371/journal.pone.0298418.
The mechanism of regulation of -catalyzed hydrolysis.
Falzone M, MacKinnon R Proc Natl Acad Sci U S A. 2023; 120(48):e2315011120.
PMID: 37991948 PMC: 10691244. DOI: 10.1073/pnas.2315011120.
MITF deficiency accelerates GNAQ-driven uveal melanoma.
Phelps G, Hagen H, Amsterdam A, Lees J Proc Natl Acad Sci U S A. 2022; 119(19):e2107006119.
PMID: 35512098 PMC: 9172632. DOI: 10.1073/pnas.2107006119.